| Nov 7 |
Accelerate Diagnostics GAAP EPS of -$0.59 misses by $0.12, revenue of $2.98M misses by $0.02M
|
| Nov 7 |
Accelerate Diagnostics: Q3 Earnings Snapshot
|
| Nov 7 |
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results
|
| Nov 6 |
Accelerate Diagnostics Q3 Earnings Preview
|
| Oct 9 |
Accelerate Diagnostics Inc (AXDX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
| Oct 1 |
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System
|
| Oct 1 |
FDA approves Accelerate Arc system to identify microbial infections
|
| Sep 30 |
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System
|
| Aug 10 |
Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript
|
| Aug 8 |
Accelerate Diagnostics GAAP EPS of -$0.50 beats by $0.05, revenue of $3M in-line
|
